Average Co-Inventor Count = 9.61
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (25 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (20 from 2,405 patents)
3. Dendreon Corporation (5 from 53 patents)
4. Southern Research Institute (3 from 203 patents)
5. Other (1 from 832,912 patents)
6. Merck Canada Inc. (1 from 40 patents)
7. Merck Sharp & Dohme LLC (1 from 9 patents)
8. Merck Shapr & Dohme Corp. (1 from 1 patent)
48 patents:
1. 12516046 - 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors
2. 12247031 - Cyclobutyl pyrazolopyrimidine PDE9 inhibitors
3. 12195445 - 2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors
4. 11802122 - 2-oxoimidazolidine-4-carboxamides as NA1.8 inhibitors
5. 11377438 - 2-amino-n-heteroaryl-nicotinamides as Na1.8 inhibitors
6. 11028092 - Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
7. 10934294 - Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
8. 10806724 - Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use
9. 10335399 - Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2—negative allosteric modulators, compositions, and their use
10. 10072003 - Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
11. 9868733 - Azabenzimidazole tetrahydrofuran derivatives
12. 9650375 - Indole derivatives useful as anti-diabetic agents
13. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives
14. 9433621 - Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
15. 9416154 - 5'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases